arrow
M

Marlène Pasquet

centre hospitalo-universitaire de toulouse
H指数:32
被引数:3,563

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sinusoidal obstruction syndrome in children with B‐acute lymphoblastic leukemia (B‐ALL) treated with inotuzumab ozogamicin: Results from the ITCC‐059 trial

窦性阻塞综合征在用伊诺妥单抗奥佐米星治疗B-急性淋巴细胞白血病(B-ALL)的儿童中的发生情况:ITCC-059试验结果

2026-08-210
OAAI
Inotuzumab ozogamicin in paediatric very high risk first B-cell acute lymphoblastic leukaemia relapse (ITCC-059): a multicentre, single-arm, phase 2 trial

奥佐米星-伊诺他珠单抗在儿科极高危首次B细胞急性淋巴细胞白血病复发中的应用(ITCC-059):一项多中心、单臂、II期临床试验

2026-06-150
PRE
COAGULATIVE ABNORMALITIES IN PATIENTS WITH CBL SYNDROME
2025-11-010
OAAI
Childhood isolated C3d-positive AIHA: favorable prognosis but rare relapse or associated immunodeficiency

儿童孤立性C3d阳性AIHA:预后良好,但复发或相关免疫缺陷罕见

2025-10-240
OAAI
Azathioprine or mycophenolate mofetil for pediatric autoimmune cytopenia: A propensity score-matched study

硫唑嘌呤或霉酚酸吗啉酯治疗儿童自身免疫性血细胞减少症:一项倾向性评分匹配研究

2025-10-210
OAAI
Identification of Hepatic-like Erythropoietin with Enhanced Activity As a New Cause of Hereditary and Acquired Erythrocytosis

鉴定具有增强活性的肝样促红细胞生成素作为遗传性和获得性红细胞增多症的新病因

BLOOD
IF23.1
2024-11-250
PRE
2q33 Deletions Underlying Syndromic and Non-syndromic CTLA4 Deficiency
2024-11-230
PRE
Results of the prospective EORTC Children Leukemia Group study 58081 in precursor B- and T-cell acute lymphoblastic leukemia
2024-11-130
OAAI
How to Administer Pegaspargase during Induction Treatment of Acute Lymphoblastic Leukemia in Children and Adolescents? Results of the Caall-F01, a Multicentre Randomized Clinical Trial from the French Pediatric Cancer Society (SFCE)

如何在儿童和青少年急性淋巴细胞白血病的诱导治疗期间使用Pegaspargase?Caall-F01研究结果,一项来自法国儿科肿瘤学会(SFCE)的多中心随机临床试验。

BLOOD
IF23.1
2024-11-050
PRE
Autoinflammation in patients with leukocytic CBL loss of heterozygosity is caused by constitutive ERIC-mediated monocyte activation

白细胞CBL杂合性丧失患者的自身炎症是由组成型ERIC介导的单核细胞激活引起的

2024-10-150
PRE
Excellent outcome of children/adolescents with primary mediastinal large B-cell lymphoma treated with a FAB/ LMB-based chemotherapy regimen with rituximab
2024-07-111
OAAI
Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcome
2024-04-230
OAAI
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency
2024-02-145
OA
Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL

B-all的白血病启动活性需要干细胞样重编程

2023-11-062
OAAI
Molecular and clinicopathologic characterization of pediatric histiocytoses
2023-04-2817
OA
Impact of age at diagnosis, sex, and immunopathological manifestations in 886 patients with pediatric chronic immune thrombocytopenia

886例儿童慢性免疫性血小板减少症患者的诊断年龄,性别和免疫病理表现的影响

2023-03-218
OA